No. of Recommendations: 1
On the front page, no less, of today's Los Angeles Times:

Inhaled Insulin Wins U.S. Approval
By Denise Gellene and Thomas H. Maugh II, Times Staff Writers

Federal regulators Friday approved the first inhaled insulin treatment, offering millions of diabetics a chance to ease the grueling ritual of repeated daily injections.

Called Exubera, the drug allows patients to control their blood-sugar levels by inhaling a fine insulin powder through a flashlight-size device. The drug, to be marketed by Pfizer Inc., could reduce or eliminate the need for before-meal insulin shots.


Insurance companies have not yet said if they will cover the drug, but are likely to do so because uncontrolled diabetes can lead to far more costly health problems, said Zach Wagner, an analyst with Edward Jones.

"We're saying it will be a blockbuster," with eventual sales of $1 billion a year, he said.,0,527827.story?coll=la-home-headlines

David, who is long PFE.
Print the post  



The 2009 BMW Method Conference has been cancelled, due to minimum attendance numbers not being met. We hope to continue the annual BMW Method Conference tradition next fall.

Learn about the first four conferences on the BMW Method Website.

The BMW Method FAQ

BMW Method Website
Annual Conference Videos and Other Resources & Services
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.